Analysis of the Cataract Surgical Device Market: Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Predictions

The cataract surgery devices market is poised for growth, projected to expand from USD 9.25 billion in 2025 to USD 12.47 billion by 2033, with a CAGR of 3.80%. Key drivers include rising cataract incidences among aging populations, technological advancements, and increased awareness of early intervention. Devices such as phacoemulsification systems, femtosecond lasers, and ophthalmic viscosurgical tools enhance precision and recovery times in surgeries. Major players like Alcon, Johnson & Johnson, and Carl Zeiss Meditec lead innovation. The global demand for high-quality ophthalmic care fuels market expansion.

Cataract Surgery Devices Market Overview

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) – The “Cataract Surgery Devices Market Companies Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts” has been added to ResearchAndMarkets.com’s offering.

It is expected that the cataract surgery devices market will grow from USD 9.25 billion in 2025 to USD 12.47 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 3.80% during the forecast period of 2025-2033.

An increased incidence of cataracts among aging populations, along with technological advancements in surgical tools, and a growing awareness of the importance of early treatment are key factors driving the adoption of modern cataract surgeries worldwide.

Cataract surgery devices, such as phacoemulsification systems, femtosecond lasers, and ophthalmic viscosurgical devices, are specialized instruments designed to remove clouded natural lenses from the eye. They replace these lenses with artificial intraocular lenses (IOLs), restoring clear vision. Modern surgical technologies make procedures minimally invasive, highly precise, and quicker, leading to faster recovery times and improved visual outcomes.

The global demand for cataract surgery devices is on the rise, given that cataracts continue to be a leading cause of blindness worldwide, particularly among older adults. Enhanced safety protocols in surgeries and improved access to healthcare—along with favorable reimbursement policies—have further accelerated the adoption of these technologies.

Innovations such as laser-assisted surgery and the integration of digital imaging technologies are contributing to higher success rates and are attracting patients seeking premium vision correction options. Increasing awareness about preventable blindness, expanding healthcare infrastructure, and a demand for high-quality ophthalmic care underscore the sustained growth of the cataract surgery devices market globally.